Skip to main content

Articles

Page 31 of 34

  1. With the introduction of newer atypical antipsychotic agents, a question emerged, concerning their use as complementary pharmacotherapy or even as monotherapy in mental disorders other than psychosis.

    Authors: Konstantinos N Fountoulakis, Ioannis Nimatoudis, Apostolos Iacovides and George Kaprinis

    Citation: Annals of General Hospital Psychiatry 2004 3:4

    Content type: Review

    Published on:

  2. Fluoxetine was the first molecule of a new generation of antidepressants, the Selective Serotonin Re-uptake Inhibitors (SSRIs). It is recurrently the paradigm for the development of any new therapy in the trea...

    Authors: Andrea Rossi, Alessandra Barraco and Pietro Donda

    Citation: Annals of General Hospital Psychiatry 2004 3:2

    Content type: Review

    Published on:

  3. Tardive dyskinesia (TD) is a major limitation of older antipsychotics. Newer antipsychotics have various other side effects such as weight gain, hyperglycemia, etc. In a previous study we have shown that an in...

    Authors: Chara A Zika, Ioannis Nicolaou, Antonis Gavalas, George V Rekatas, Ekaterini Tani and Vassilis J Demopoulos

    Citation: Annals of General Hospital Psychiatry 2004 3:1

    Content type: Primary research

    Published on: